Categories: News

Harrow Health to Announce Fourth Quarter and Year-End 2020 Financial Results on March 8, 2021

NASHVILLE, Tenn., Feb. 25, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2020, on Monday, March 8, 2021, after the Nasdaq market close. The Company will also post its fourth quarter Letter to Shareholders to the “Investors” section of its website, harrowinc.com. Harrow Health will host a conference call and live webcast at 4:45 p.m. Eastern time to discuss the results and provide a business update.

Conference Call Details:  
Date: Monday, March 8, 2021
Time: 4:45 p.m. Eastern time
Participant Dial-in: (888) 506-0062 (U.S.)
(973) 528-0011 (International)
Replay Dial-in (Passcode 39840):
(telephonic replay through April 8, 2021)
(877) 481-4010 (U.S.)
(919) 882-2331 (International)
Webcast:
(online replay through June 8, 2021)
harrowinc.com

About Harrow Health
Harrow Health, Inc. (NASDAQ: HROW) is an ophthalmic-focused healthcare company. The Company owns ImprimisRx, the nation’s leading ophthalmology outsourcing and pharmaceutical compounding business, which was founded in 2014. Harrow Health also holds large equity positions in Eton Pharmaceuticals, Surface Ophthalmics and Melt Pharmaceuticals, all of which started as Harrow Health subsidiaries. Harrow Health also owns royalty rights in four clinical-stage drug candidates being developed by Surface Ophthalmics and Melt Pharmaceuticals. For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com.

Contact:
Jamie Webb, Director of Communications and Investor Relations
jwebb@harrowinc.com
615-733-4737

 

Staff

Recent Posts

Babson Diagnostics Wins Best Abstract Award at 2025 EFLM Preanalytical Conference

EFLM recognizes Babson Diagnostics for innovations in sample collection and preparation AUSTIN, TX / ACCESS…

3 hours ago

New Obesity Medicine Association Initiative Aims to Scale High-Impact Obesity Healthcare Improvements Nationwide

Centennial, Colorado--(Newsfile Corp. - December 18, 2025) - The Obesity Medicine Association (OMA) is pleased…

4 hours ago

Attune’s to Support Poppy Health’s $38M ARPA-H BREATHE Project in the U.S. Schools

VIENNA, Va., Dec. 18, 2025 /PRNewswire/ -- Attune announced today that the company will play…

6 hours ago

Attune’s to Support Poppy Health’s $38M ARPA-H BREATHE Project in the U.S. Schools

VIENNA, Va., Dec. 18, 2025 /PRNewswire/ -- Attune announced today that the company will play…

6 hours ago

Invacare® America Division ASL Launches Revolutionary iON Integrated Drive Control System to Help Enhance Wheelchair Users’ Independence and Mobility

New platform integrates wireless connectivity, communications and navigation to help enhance users' control over activities…

6 hours ago

Alleva Introduces InCheck: Transforming Behavioral Health Compliance Into a Year-Round System

LAGUNA NIGUEL, Calif., Dec. 18, 2025 /PRNewswire/ -- Alleva, a leader in behavioral health technology, announced…

6 hours ago